According to the info. released by NMPA, the certificate of the new type of medical equipment of 2019-nCov nucleic acid reagent kit (CRISPR with immunochromatography method) has been approved.

According to CBS News in the United States, due to the new crown epidemic or exposure, a total of about 1,500 Mayo Clinic health system staff are unable to work.

On November 25, 2020（Beijing time）, the US Food and Drug Administration (FDA) issued an emergency use authorization (EUA) to Innovita Biological ' novel coronavirus Innovita 2019-nCoV Ab Test (Colloidal gold).

Studies have shown that COVID-19 correlates with lymphopenia and low T cell concentrations, and mild COVID-19 correlates with a strong T cell response to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.

As one of the fastest growing segments of the in vitro diagnostics market, companion diagnostics is expected that its share in the in vitro diagnostics market will reach 14% in 2021.

In the first three quarters, net profit soared by 107 times, realizing a net profit of 2.013 billion yuan. Sansure Biotech: cash dividend is here!

In November 2020, three in-vitro diagnostic-related companies, AVE Science & Technology Industry Co., Ltd , Assure Tech (Hangzhou) Co., Ltd, and Novogene, had the first launch of the sci-tech innovation board.

Shanghai Academy of Experimental Medicine (SAEM) held the opening ceremony at the conference room of Shanghai Tomorrow Square in Nov. 18th, 2020.

The listing wave of Chinese IVD companies should pay more attention to the historical investment opportunities in this market rather than the industry dividends due to public health incidents.

On November 15, 2020, the Regional Comprehensive Economic Partnership Agreement (RCEP), including the ten ASEAN countries and 15 countries.

Identifying the genetic cause of epilepsy using whole genome sequencing could lead to better disease management.

Researchers from Duke-NUS Medical School, Erasmus University Medical Center, Yale-NUS College and Duke University have found a potential way to predict who will respond to cancer therapies that block Wnt production.

At the present stage, although there are occasional small outbreaks in China, the prevention and control measures are generally appropriate and the resumption of work and production is proceeding in an orderly manner.

The 3rd China International Import Expo (CIIE) was held at National Exhibition and Convention Center (Shanghai) from November 5th to 10th.

On November 8, during the 3rd CIIE, SANSURE BIOTECH INC. and the world leader in scientific services, Thermo Fisher Scientific (China) ) Co., Ltd. ("Thermo Scientific"), signed a memorandum of strategic partnership.